These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas. Elkashty OA; Abu Elghanam G; Su X; Liu Y; Chauvin PJ; Tran SD Carcinogenesis; 2020 Jun; 41(4):458-466. PubMed ID: 31742606 [TBL] [Abstract][Full Text] [Related]
9. Decreased expression of cell adhesion genes in cancer stem-like cells isolated from primary oral squamous cell carcinomas. Mishra A; Sriram H; Chandarana P; Tanavde V; Kumar RV; Gopinath A; Govindarajan R; Ramaswamy S; Sadasivam S Tumour Biol; 2018 May; 40(5):1010428318780859. PubMed ID: 29888653 [TBL] [Abstract][Full Text] [Related]
10. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Zöller M Nat Rev Cancer; 2011 Apr; 11(4):254-67. PubMed ID: 21390059 [TBL] [Abstract][Full Text] [Related]
11. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma. Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202 [TBL] [Abstract][Full Text] [Related]
12. Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis. Li W; Ma H; Zhang J; Zhu L; Wang C; Yang Y Sci Rep; 2017 Oct; 7(1):13856. PubMed ID: 29062075 [TBL] [Abstract][Full Text] [Related]
13. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer. Wakamatsu Y; Sakamoto N; Oo HZ; Naito Y; Uraoka N; Anami K; Sentani K; Oue N; Yasui W Pathol Int; 2012 Feb; 62(2):112-9. PubMed ID: 22243781 [TBL] [Abstract][Full Text] [Related]
14. CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Hurt EM; Kawasaki BT; Klarmann GJ; Thomas SB; Farrar WL Br J Cancer; 2008 Feb; 98(4):756-65. PubMed ID: 18268494 [TBL] [Abstract][Full Text] [Related]
15. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers. Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682 [TBL] [Abstract][Full Text] [Related]
16. Putative cancer stem cells are present in surgical margins of oral squamous cell carcinoma. Lazarevic M; Milosevic M; Trisic D; Toljic B; Simonovic J; Nikolic N; Mikovic N; Jelovac D; Petrovic M; Vukadinovic M; Milasin J J BUON; 2018; 23(6):1686-1692. PubMed ID: 30610795 [TBL] [Abstract][Full Text] [Related]
17. Embryonic stem cells markers Oct4 and Nanog correlate with perineural invasion in human salivary gland mucoepidermoid carcinoma. Destro Rodrigues MF; Sedassari BT; Esteves CM; de Andrade NP; Altemani A; de Sousa SC; Nunes FD J Oral Pathol Med; 2017 Feb; 46(2):112-120. PubMed ID: 27131799 [TBL] [Abstract][Full Text] [Related]
18. CD147/EMMPRIN and CD44 are potential therapeutic targets for metastatic prostate cancer. Hao JL; Cozzi PJ; Khatri A; Power CA; Li Y Curr Cancer Drug Targets; 2010 May; 10(3):287-306. PubMed ID: 20370680 [TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer. Kodama H; Murata S; Ishida M; Yamamoto H; Yamaguchi T; Kaida S; Miyake T; Takebayashi K; Kushima R; Tani M Br J Cancer; 2017 Jan; 116(2):186-194. PubMed ID: 27931044 [TBL] [Abstract][Full Text] [Related]
20. Predictive Value of CD44 in Muscle-Invasive Bladder Cancer and Its Relationship with IL-6 Signaling. Wu CT; Lin WY; Chen WC; Chen MF Ann Surg Oncol; 2018 Nov; 25(12):3518-3526. PubMed ID: 30128900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]